Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 08-2020 | 08-2019 | 08-2018 | 08-2017 | 08-2007 | |
| Sales | 315 | 223 | 433 | 0 | 0 |
| Cost of Goods | 99 | 23 | 25 | N/A | N/A |
| Gross Profit | 215 | 200 | 408 | N/A | N/A |
| Operating Expenses | 4,464 | 3,085 | 6,427 | 0 | 0 |
| Operating Income | -4,149 | -2,862 | -5,994 | N/A | N/A |
| Other Income | 0 | -1,296 | -615 | 0 | 0 |
| Pre-tax Income | -4,149 | -4,158 | -6,609 | 0 | 0 |
| Net Income Continuous | -4,149 | -4,158 | -6,609 | N/A | N/A |
| Net Income Discontinuous | 64 | N/A | N/A | N/A | N/A |
| Minority Interests | -151 | N/A | N/A | N/A | N/A |
| Net Income | $-3,934 | $-4,158 | $-6,609 | $N/A | $N/A |
| EPS Basic Total Ops | -1.47 | -1.50 | -2.70 | N/A | N/A |
| EPS Basic Continuous Ops | -1.50 | -1.61 | -2.80 | N/A | N/A |
| EPS Basic Discontinuous Ops | 0.02 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -1.47 | -1.50 | -2.70 | N/A | N/A |
| EPS Diluted Continuous Ops | -1.50 | -1.61 | -2.80 | N/A | N/A |
| EPS Diluted Discontinuous Ops | 0.02 | N/A | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.50 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-4,003 | $-2,802 | $-5,992 | $N/A | $N/A |